Endocrinology, Vol 130, 945-953, Copyright © 1992 by Endocrine Society

ARTICLES

Calcium signalling in single growth hormone-releasing factor-responsive pituitary cells

L Cuttler, SR Glaum, BA Collins and RJ Miller
Department of Pediatrics, Case Western Reserve University, Cleveland, Ohio 44106.

The release of pituitary GH appears to be critically dependent on alterations in the free intracellular Ca2+ concentration ([Ca2+]i). However, little is known about the nature of Ca2+ signalling within normal pituitary cells. We, therefore, examined [Ca2+]i patterns in individual cultured pituicytes of adult male rats under basal conditions and in response to GH regulatory agents, using the calcium- sensitive dye fura-2 together with digital imaging microscopy. Perfusion of cultured anterior pituitary cells with GH-releasing factor (GHRF) resulted in a marked increase in [Ca2+]i in specific pituitary cells. These cells did not respond to other hypothalamic secretagogues (GnRH, TRH, or CRF), and there was no evidence of desensitization on repetitive administration of GHRF. Somatotrophs (n = 134) exhibited spontaneous oscillations of [Ca2+]i in the basal state, with considerable heterogeneity of oscillatory patterns among cells. After application of a near-maximal stimulatory dose of GHRF (1 nM), there was a striking 2.2-fold increase in the amplitude of [Ca2+]i oscillations and only a modest increase in their frequency. Forskolin (1 microM) augmented somatotroph [Ca2+]i in patterns similar to those of GHRF. Somatostatin (10 nM) abolished the [Ca2+]i response to GHRF (n = 26); this reflected a marked reduction in the amplitude of [Ca2+]i oscillations and a slight reduction in their frequency. Ca(2+)-free medium or the Ca2+ channel antagonist nimodipine (0.1-1 microM) suppressed the Ca2+ stimulatory effect of GHRF. Conversely, the Ca2+ channel agonist BAY K8644 (1 microM) strikingly augmented the GHRF- induced rise in [Ca2+]i, with a major stimulatory effect on the amplitude of [Ca2+]i oscillations and no observed effect on their frequency. In summary, GHRF and other hypothalamic secretagogues increase [Ca2+]i in pituitary cells in a highly specific manner, consistent with the known specificity of their effects on hormone release. Somatotrophs exhibit spontaneous rhythmic oscillation of [Ca2+]i in the basal state. Known regulators of GH release markedly alter the [Ca2+]i oscillatory pattern in characteristic manners, exerting predominant effects on the amplitude of [Ca2+]i pulses and lesser effects on their frequency. These striking effects of GH regulatory agents on pituitary Ca2+ signalling are consistent with the concept that modulation of [Ca2+]i is a critical mediator of somatotroph function.

This article has been cited by other articles:

				W. K. Yunker, S. Smith, C. Graves, P. J. Davis, S. Unniappan, J. E. Rivier, R. E. Peter, and J. P. Chang Endogenous Hypothalamic Somatostatins Differentially Regulate Growth Hormone Secretion from Goldfish Pituitary Somatotropes in Vitro Endocrinology, September 1, 2003; 144(9): 4031 - 4041. [Abstract] [Full Text] [PDF]

				C. M. Lasko, A. I. Korytko, W. B. Wehrenberg, and L. Cuttler Differential GH-releasing hormone regulation of GHRH receptor mRNA expression in the rat pituitary Am J Physiol Endocrinol Metab, April 1, 2001; 280(4): E626 - E631. [Abstract] [Full Text] [PDF]

				D. Zivadinovic, F. Van Goor, D. Yuan, T.-a. Koshimizu, and S. S. Stojilkovic Expression of Ca2+-Mobilizing EndothelinA Receptors and Their Role in the Control of Ca2+ Influx and Growth Hormone Secretion in Pituitary Somatotrophs J. Neurosci., September 15, 1999; 19(18): 7721 - 7731. [Abstract] [Full Text] [PDF]